Vanishing white matter: deregulated integrated stress response as therapy target. [electronic resource]
- Annals of clinical and translational neurology 08 2019
- 1407-1422 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2328-9503
10.1002/acn3.50826 doi
Acetamides--pharmacology Activating Transcription Factor 4--metabolism Adaptor Proteins, Signal Transducing--metabolism Animals Astrocytes--metabolism Brain--metabolism Cell Cycle Proteins--metabolism Cerebellum--drug effects Corpus Callosum--drug effects Cyclohexylamines--pharmacology Eukaryotic Initiation Factor-2B--genetics Humans Leukoencephalopathies--drug therapy Mice Mutation Protein Biosynthesis Protein Serine-Threonine Kinases--metabolism White Matter--pathology